Case series:Polymyxin B

2 trials

Sponsors

The Second Xiangya Hospital of Central South University, Huashan Hospital, Fudan University

Conditions

Critical illnessHospital-acquired Pneumonia (HAP)/ Ventilator-associated Pneumonia (VAP)

Phase 4

PK/PD study and dose optimization of polymyxin B in critically ill patients

RecruitingChiCTR1900022231

The Second Xiangya Hospital of Central South UniversityCritical illness

Start: 2019-04-01Updated: 2019-04-01

A clinical study of the concentration and penetration rate of polymyxin B in plasma and pulmonary epithelial lining fluid of HAP/VAP patients caused by carbapenem-resistant Gram-negative bacilli in the treatment of aerosol inhalation and combined intravenous infusion of polymyxin B sulfate

Active, not recruitingChiCTR2200062227

Huashan Hospital, Fudan UniversityHospital-acquired Pneumonia (HAP)/ Ventilator-associated Pneumonia (VAP)

Start: 2022-07-30Updated: 2023-04-03